Enhertu approved in the EU as first HER2-directed therapy for patients with HR-positive, HER2-low or...

TIVDAK (Tisotumab vedotin) approved by European Commission for previously treated recurrent or metastatic Cervical cancer

Mabwell announces NMPA approval to initiate clinical trial of novel B7-H3-targeting ADC for advanced solid...

SPARC announces submission of IND application for SBO-154 to USFDA

OBI has submitted the IND application of a Phase 1/2 human clinical trial for OBI-902...

Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D centre in Basel